Old Web
English
Sign In
Acemap
>
authorDetail
>
Joachim-Friedrich Kapp
Joachim-Friedrich Kapp
Medicine
Immunology
Molecular biology
Phosphodiesterase inhibitor
Diabetes mellitus
5
Papers
392
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity
2017
International Journal of Cancer
Theresa Schwaiger
Michael R. Knittler
Christian Grund
Angela Roemer-Oberdoerfer
Joachim-Friedrich Kapp
Markus M. Lerch
Thomas C. Mettenleiter
Julia Mayerle
Ulrike Blohm
Show All
Source
Cite
Save
Citations (15)
Traitement de la myocardiopathie et de la dysfonction endotheliale
2005
Georg Groetzbach
Joachim-Friedrich Kapp
Uwe Kuehl
Heinz-Peter Schultheiss
Olaf Sowade
Claus-Steffen Stuerzebecher
Show All
Source
Cite
Save
Citations (0)
The Specific Type-4 Phosphodiesterase Inhibitor Mesopram Alleviates Experimental Colitis in Mice
2003
Journal of Pharmacology and Experimental Therapeutics
Florian Loher
Kathrin Schmall
Philipp Freytag
Nikola Landauer
Roland Hallwachs
Christian Bauer
Britta Siegmund
Florian Rieder
Hans-Anton Lehr
Marc Dauer
Joachim-Friedrich Kapp
Stefan Endres
Andreas Eigler
Show All
Source
Cite
Save
Citations (32)
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome: An Epidemiologic Study From West Germany
1991
Archives of Dermatology
Erwin Schöpf
Annette Stühmer
Berthold Rzany
Norbert Victor
Reinhardt Zentgraf
Joachim-Friedrich Kapp
Show All
Source
Cite
Save
Citations (345)
Neue phenylessigsaeure-derivate
1978
Gerald Kirsch
Joachim-Friedrich Kapp
Clemens Rufer
Show All
Source
Cite
Save
Citations (0)
1